中文产业新闻精选评分63Chinese source
翰森制药TYK2抑制剂HS-10374三期临床达到共同主要终点
翰森制药TYK2抑制剂HS-10374 III期临床成功，银屑病治疗再添新候选药物
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
翰森制药TYK2抑制剂HS-10374 III期临床成功，银屑病治疗再添新候选药物
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.